passages.id: split_8_test_1066_passage
passages.type: progene_text
passages.text: In a multivariate analysis , the only factors associated with better survival were favorable response to neoadjuvant chemotherapy ( P = .04 ) and receipt of tamoxifen ( P = .06 ) ; however , the benefit of tamoxifen was only demonstrated in patients with ER - positive breast cancer .